Dana-Farber Cancer Institute
Boston, Massachusetts, United StatesPurpose
to provide immunogens and a vaccine strategy to elicit broadly neutralizing antibodies (BNAbs) against the HIV-1 gp41 membrane proximal external region (MPER) segment affording protective global immunity to prevent HIV-1/AIDS
Grantee
Division
Global Health
Date
JULY 2014
Region served
GLOBAL
Committed amount
$2,935,657
Grant topic
HIV
Duration (months)
64
Grantee location
Boston, Massachusetts, United States
Related work
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.